Exploring the relationship between self-reported urinary tract infections to quality of life and associated conditions: insights from the spinal cord injury Community Survey

Spinal Cord ◽  
2019 ◽  
Vol 57 (12) ◽  
pp. 1040-1047
Author(s):  
Jennifer A. Locke ◽  
Blayne Welk ◽  
Andrew Macnab ◽  
Carly S. Rivers ◽  
Dilnur Kurban ◽  
...  
2016 ◽  
Vol 40 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Jacinthe J. E. Adriaansen ◽  
Floris W. A. van Asbeck ◽  
Marga Tepper ◽  
Willemijn X. Faber ◽  
Johanna M. A. Visser-Meily ◽  
...  

2019 ◽  
Vol 25 (4) ◽  
pp. 331-339 ◽  
Author(s):  
Felicia Skelton-Dudley ◽  
James Doan ◽  
Katie Suda ◽  
S. Ann Holmes ◽  
Charlesnika Evans ◽  
...  

Background: Catheter-associated urinary tract infection (CAUTI) is associated with increased morbidity and mortality and influences the quality of life of patients with spinal cord injury (SCI). Objectives: This clinical review aims to highlight the unique surveillance, prevention, diagnosis, and management challenges of CAUTI in the SCI population. Methods: Narrative review of the current literature on catheter use in persons with SCI was conducted to determine gaps in knowledge and opportunities for improvement. Results: Surveillance of CAUTI is challenging in the SCI population as the ability to detect symptoms used to diagnose CAUTI (ie, suprapubic pain, dysuria) is impaired. In terms of prevention of CAUTI, current strategies refocus on appropriate catheter insertion and care and early removal of catheters, which is not always feasible for persons with SCI. Prophylactic antibiotics, nutraceuticals, and coated catheters show limited efficacy in infection prevention. Diagnosing CAUTI after SCI is challenging, often resulting in an overdiagnosis of CAUTI when truly asymptomatic bacteriuria exists. In the management of CAUTI in patients with SCI, the use of multiple antibiotics over time in an individual increases the rate of multidrug-resistant organisms; therefore, the exploration of novel non-antibiotic treatments is of importance. The patient experience should be at the center of all these efforts. Conclusion: Better diagnostic tools or biomarkers are needed to define true CAUTI in people with SCI. SCI-specific evidence to inform catheter management and CAUTI treatment guidelines is needed, with the goal to minimize catheter-related harm, reduce antibiotic resistance, and improve satisfaction and overall quality of life for SCI patients.


2016 ◽  
Vol 39 (5) ◽  
pp. 491-496 ◽  
Author(s):  
Catherine S. Wilson ◽  
Martin Forchheimer ◽  
Allen W. Heinemann ◽  
Anne Marie Warren ◽  
Cheryl McCullumsmith

2011 ◽  
Vol 92 (7) ◽  
pp. 1027-1033 ◽  
Author(s):  
Melissa S. Riggins ◽  
Padmaja Kankipati ◽  
Michelle L. Oyster ◽  
Rory A. Cooper ◽  
Michael L. Boninger

Sign in / Sign up

Export Citation Format

Share Document